Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets... Show more
RVTY is expected to report earnings to fall 32.99% to 95 cents per share on April 28
Q1'25
Est.
$0.95
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.10
Q1'24
Beat
by $0.04
The last earnings report on January 31 showed earnings per share of $1.42, beating the estimate of $1.37. With 1.70M shares outstanding, the current market capitalization sits at 12.76B.